“Mix‐and‐Match”: Self‐Sorting Assembly Governed Supramolecular Polymeric Nanomedicine for Boosting Combined Chemo/Phototherapy
Precise cancer nanomedicine requires rational molecular instructions of therapeutic agents. Harnessing the structure-property-function relationships represents a practical strategy toward smart and effective nanomedicine. A structurally novel hydrogen-bonded (H-bonded) supramolecular nanoformulation generated by orthogonal self-sorting assembly of chemo-prodrug (FPtF) and phototherapeutics (BPeB) is here reported, to reach an autonomous nanomedicine with improved anti-tumor efficacy by combining chemo/phototherapy (CT/PT). The high-fidelity of H-bonding modularity from privileged heterocomplementary diaminopyridine/5-fluorouracil (DAP/FU) and Hamilton wedge/barbiturate (HW/Ba) pairs, respectively enable the precise spatial control of binding interactions toward FPtF and BPeB, in turn allowing the self-sorting process and specific "mix-and-match" capability. To directly stimulate phototherapy from BPeB via near-infrared (NIR) light, spectral matched upconversion nanoparticles (UCNPs, β-NaYF<sub>4</sub>:Yb,Er) are encapsulated simultaneously. As a result, supramolecular polymeric nanomicelles, i.e., F/B/U@PHDO, are readily fabricated. Moreover, distinct H-bonding association constant (Ka) of DAP/FU (≈10<sup>2</sup> M<sup>-1</sup>) and HW/Ba (≈10<sup>4-5</sup> M<sup>-1</sup>) pairs reflect different strengths and stabilities of H-bonds, thus endowing the programmable H-bonding dissociation, accompanied with the chemo-prodrug release through pH/thermal-stimuli. Therapeutic regime with appreciated anti-tumor outcomes is ultimately accomplished via combined CT/PT. The privileged opportunities offered by self-sorting design are anticipated to point to new paradigm toward precise nanomedicine for cancer therapy.
Authors
- Senbin Chen (ORCID: https://orcid.org/0000-0001-5599-6819)
- Zeke Li (ORCID: https://orcid.org/0009-0009-1571-048X)
- Frédéric Lortie (ORCID: https://orcid.org/0000-0003-4580-497X)
- Wolfgang H. Binder (ORCID: https://orcid.org/0000-0003-3834-5445)
- Jintao Zhu (ORCID: https://orcid.org/0000-0002-8230-3923)
- Yanggui Wu
- Julien Bernard
- Ting Li (ORCID: https://orcid.org/0000-0001-6037-8097)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Huazhong University of Science and Technology (CN)
- Institut National des Sciences Appliquées de Lyon (FR)
- Martin Luther University Halle-Wittenberg (DE)
- Université Jean Monnet (FR)
Publication Details
- Journal
- Advanced Materials
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1002/adma.202502416
- Citations
- 8
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 5.39
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China